Metabolomic Biomarkers for Detection, Prognosis and Identifying Recurrence in Endometrial Cancer

Metabolic reprogramming is increasingly recognised as one of the defining hallmarks of tumorigenesis. There is compelling evidence to suggest that endometrial cancer develops and progresses in the context of profound metabolic dysfunction. Whilst the incidence of endometrial cancer continues to rise...

Full description

Saved in:
Bibliographic Details
Published in:Metabolites
Main Authors: Njoku, Kelechi, Sutton, Caroline J.J, Whetton, Anthony D., Crosbie, Emma J.
Format: Artigo
Language:Inglês
Published: MDPI 2020
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7463916/
https://ncbi.nlm.nih.gov/pubmed/32751940
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/metabo10080314
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items